DLB
Dolby Laboratories, Inc.
NYSE · Technology · Information Technology Services · US
$61.66
−0.42%Year over year
Reported trailing growth
- Revenue
- +0.6%
- EBITDA
- -9.4%
- EBIT
- -15.4%
- EPS
- -13.5%
- Free cash flow
- -21.4%
- Operating cash flow
- -6.0%
Forward estimates
Based on analyst estimates
- Revenue
- +7.6%
- EBITDA
- +63.3%
- EPS
- +90.5%
Three-year CAGR
- Revenue
- +2.5%
- EBITDA
- +5.9%
- EBIT
- +6.8%
- Net income
- +11.5%
- EPS
- +13.1%
- Free cash flow
- +18.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026